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Background: Underweight eating disorders (EDs) are notoriously difficult to treat, although a
growing evidence base suggests that outpatient cognitive behaviour therapy for EDs (CBT-ED)
can be effective for a large proportion of individuals. Aims: To investigate the effectiveness
of CBT-ED for underweight EDs in a ‘real-world’ settings. Method: Sixty-three adults with
underweight EDs (anorexia nervosa or atypical anorexia nervosa) began outpatient CBT-ED in
a National Health Service setting. Results: Fifty-four per cent completed treatment, for whom
significant changes were observed on measures of ED symptoms, psychological distress and
psychosocial impairment. There was also a large effect on body weight at end-of-treatment.
Conclusions: The results suggest that good outcomes can be achieved by the majority of those
who complete treatment, although treatment non-completion remains a significant barrier to
recovery. Future studies should focus on improving treatment retention, as evidence suggests
that CBT-ED in ‘real-world’ settings is effective.
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Introduction
In the field of eating disorders (EDs), a number of evidence-based treatments have ‘earned their
stripes’, with those based on cognitive behavioural principles often foremost in the treatment of
these illnesses in adults (Steiger, 2017). Cognitive behaviour therapy for EDs, known as CBT-
ED (e.g. NICE, 2017), has been widely investigated and its efficacy supported in randomized
controlled trials and meta-analyses (e.g. see Linardon et al., 2017). However, there is often
assumed to be a gap between what is provided in research settings (where the majority of
evidence for efficacy is collected) and in ‘real-world’ settings (e.g. see Shafran et al., 2009;
Wallace and von Ranson, 2012). In order to address this, a number of recent studies have looked
at the effectiveness of evidence-based CBT-ED for adults in outpatient clinical settings (e.g.
Byrne et al., 2011; Knott et al., 2015; Rose and Waller, 2017; Serpell et al., 2013; Signorini et al.,
2017; Turner et al., 2015; Waller et al., 2014). Such studies are important as they can support
findings of well-conducted research trials (e.g. Byrne et al., 2017; Fairburn et al., 2009, 2013,
2015) and demonstrate treatment efficacy in settings where ‘there are few exclusion criteria
and where adherence to evidence-based protocols is less intensively monitored’ (Turner et al.,
2015, p. 73).
Of those studies conducted on individual CBT-ED, significant improvements have been
reported. Around 50–60% of patients complete treatment (Byrne et al., 2011; Knott et al.,
2015; Turner et al., 2015), with medium to large effect sizes observed on measures of eating
pathology and general psychiatric symptoms. Symptom change, commonly assessed with
the self-report EDE-Q (Eating Disorder Examination-Questionnaire; Fairburn and Beglin,
2008), suggests that CBT-ED improves ED attitudes as well as behaviours such as binge
eating and purging. Similarly, there is growing evidence that effects extend beyond symptom
change and are associated with improvements in quality of life (Linardon and Brennan, 2017),
although many studies have not included measures of quality of life or psychosocial impairment
(e.g. Rose and Waller, 2017).
Studies relating to the treatment of anorexia nervosa (AN) are important given the high
treatment costs and the physical and psychological co-morbidities associated with this illness
(Agras et al., 2004; Byrne et al., 2017; Halmi et al., 2005). Furthermore, atypical AN
(i.e. seen in individuals with clinically significant symptoms for whom one or more of
the key symptoms of AN, but not necessarily low weight, is absent; Fairburn and Walsh,
2002) has been understudied (e.g. Santonastaso et al., 2009) and assessing outcome can be
complex (Hughes et al., 2017). An additional component of interventions for low weight
EDs, such as AN, is the focus on weight restoration as a key goal of treatment, which
often necessitates longer duration of treatment (e.g. Byrne et al., 2017). Evaluation of CBT-
ED for AN-type disorders in ‘real-world’ settings has been limited, with such individuals
often only included as part of a larger sample (e.g. Byrne et al., 2011; Rose and Waller,
2017; Signorini et al., 2017; Turner et al., 2015). These shortcomings are also compounded
by the fact that sample sizes in treatment studies of AN are generally small, averaging
around 20 (Fairburn et al., 2013; see also Linardon et al., 2017). However, two recent
trials (Byrne et al., 2017; Fairburn et al., 2013) have reported outcomes for underweight
individuals receiving CBT-ED, and generally support findings from non-underweight studies.
Thus, although CBT-ED can be applied as a ‘transdiagnostic’ treatment (Fairburn, 2008), it
is important to generalize efficacy of such approaches to low-weight patients in ‘real-world’
settings.
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The current study aims to describe engagement and outcomes in a sample of consecutively
treated adults with underweight EDs. Specifically, it will address four key questions (Fairburn
et al., 2013): (1) what proportion of patients with underweight EDs complete CBT-ED in ‘real-
world’ clinical settings?; (2) what is the outcome of patients who complete treatment?; (3) does
psychosocial impairment also change following treatment?; and (4) do any baseline variables
predict treatment completion? Finally, given recent interest in duration of psychological
treatments for EDs (e.g. Bell et al., 2017; Waller et al., 2018), we were also interested in
the duration of treatment, and whether the number of treatment sessions was associated with
outcome.
Method
Participants
The study was conducted within a specialist outpatient Eating Disorders Service within the UK
National Health Service (NHS). The service provides assessment and treatment to adults (aged
over 17½ years) ordinarily resident within a local catchment area (total population of around
1.3 million). Patients must first be referred to the service by another healthcare professional,
such as a general practitioner, and are then offered treatment at no charge.
Participants were included in the study if they: (a) received an ICD-10 diagnosis of AN or
atypical AN (WHO, 2016) following assessment with the service; (b) had a body mass index
(BMI) <18.5 at start of treatment; (c) had a complete set of self-report measures at start of
treatment; (d) subsequently received at least one session of outpatient CBT-ED; (e) were not
receiving additional psychological therapy, inpatient or day patient treatment when starting
CBT-ED; and (f) started treatment between July 2013 and March 2017. Of note, individuals
with a diagnosis of atypical AN were excluded from the study if their BMI was greater than
18.5 kg m–2. Approval for conduct of the study was obtained from the local NHS Trust, who
noted that further ethical review was not required as this was a retrospective review of routinely
collected, de-identified data.
Initial assessment was conducted via clinical interview, lasting approximately 90 minutes.
Although similar areas are covered by clinicians, this did not adhere to a standardized interview
(e.g. the EDE; Fairburn, 2008). Where ICD-10 (WHO, 2016) diagnosis was unclear, this was
agreed upon following team discussion.
The final sample included 62 females and one male with underweight EDs (see Fig. 1). All
were asked to complete questionnaires at both pre- and post-treatment. Further demographic
information (at start of treatment) is shown in Table 1.
Measures
Height and weight were measured using a stadiometer and calibrated scales (to the nearest 5 mm
and 0.1 kg, respectively). To assess outcome, the Global score of the EDE-Q (Fairburn and
Beglin, 2008) was used to indicate ED pathology and items assessing specific ED behaviours
(i.e. objective binge eating, self-induced vomiting, laxatives, and excessive exercise) were also
used. This questionnaire also generates a number of subscales (Restraint, Eating Concern,
Shape Concern, Weight Concern). Due to significant correlation between the Shape Concern
and Weight Concern subscales, a combined subscale (Shape and Weight Concern [SWC];
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Eligible cases/allocated to CBT (n = 63)
Started treatment 
(AN, n = 43) 
Completed treatment (n = 10) 
Excluded (n = 117; 65.0%) 
• Missing significant data (e.g. at start of 
treatment) (n = 65) 
• Not meeting inclusion criteria (n = 52) 
o Still in treatment (n = 18) 
o BMI >18.5 by start of treatment (n = 33) 
o No wish for treatment (n = 1) 
Considered for study (n = 180) 
Started treatment 
(atypical AN, n = 20) 
Non-completers (n = 29; 46.0%) 
• Patient-initiated withdrawal/not engaging in 
treatment (n = 12) 
• Other primary mental health problem 
emerged/referred elsewhere (n = 9) 
• Received more intensive treatment (n = 5) 
• Lost contact with service/DNA (n = 3) 
Completed treatment (n = 24) 
Figure 1. Flow through treatment
α = 0.91) was computed (e.g. Peterson et al., 2007). The Clinical Impairment Assessment
Questionnaire (CIA; Bohn and Fairburn, 2008) Total score (α = 0.93) was used to assess the
degree of psychosocial impairment due to ED pathology and the Clinical Outcomes in Routine
Evaluation-Outcome Measure (CORE-OM; Barkham et al., 2001) Total score (α = 0.95)
provided an index of general psychological distress. All measures have good psychometric
properties and have been widely used in ED samples. Additional outcomes included number
of sessions attended, number of weeks in treatment, and BMI (calculated as weight [kg] divided
by height squared [m2]).
Remission was defined as a BMI ≥18.5, EDE-Q Global score <2.77 (one SD above a mean
from a community sample of young women; see Fairburn, 2008), and absence of binge eating
or dysfunctional weight control behaviours (i.e. self-induced vomiting, laxative use, excessive
exercise), which is in line with similar studies (e.g. Byrne et al., 2011; Turner et al., 2015).
Partial remission was defined as meeting two of these criteria (e.g. Byrne et al., 2011).
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Table 1. Demographic characteristics of the sample
All AN Atypical AN
Participant characteristics∗ patients (n = 45) (n = 18)
Age, mean (SD), years 23.63 (7.72) 23.32 (7.78) 24.39 (7.73)
Ethnic origin (N = 57)
White-British 48 (84.2%) 34 (85.0%) 14 (82.4%)
Other ethnicity 9 (15.8%) 6 (15.0%) 3 (17.6%)
Employment status (N = 52)
Employed 21 (40.4%) 14 (41.2%) 7 (38.9%)
Unemployed 4 (7.7%) 1 (2.9%) 8 (44.4%)
Full-time student 26 (50.0%) 18 (52.9%) 3 (16.7%)
Other 1 (1.9%) 1 (2.9%) –
BMI, mean (SD), kg m–2 16.84 (1.08) 16.65 (1.12) 17.33 (0.90)
Duration of illness, mean (SD), years (N = 44) 6.08 (7.38) 5.85 (6.93) 6.61 (8.64)
∗Numbers differ as data were not available for all participants.
Treatment
The treatment was a version of CBT-ED based on a leading evidence-based manual (Fairburn,
2008) and resembled that which has been recently recommended by the UK’s National Institute
for Health and Care Excellence (NICE, 2017). Most elements of Fairburn’s (2008) treatment,
known as Enhanced CBT (or CBT-E), were followed, including regular collaborative weighing,
psychoeducation (including a focus on helping patients decide to change), encouragement of
full weight restoration, jointly creating a personalized formulation, regular self-monitoring,
addressing core ED features, and sessions becoming less frequent towards the end of treatment.
However, the service did not feel able to provide twice-weekly sessions at the outset of treatment
but was otherwise consistent in delivering CBT-ED in line with guidance for the psychological
treatment of underweight patients (see Fairburn, 2008).1 Involvement of significant others
(e.g. parent, partner) was considered when it was felt that doing so would facilitate progress
(Fairburn, 2008).
Adherence was not closely monitored, although all clinicians were encouraged to deliver
treatment as per the manual and were supported by both individual and group supervision.
Group supervision took place for one hour per fortnight and focused on key elements of the
treatment manual (which was consulted at each session), helping to ensure that treatment
procedures were delivered consistently. Individual supervision was provided by one of three
senior clinical psychologists, in line with practice recommendations for case management
(typically around one hour per month). In total, 10 clinicians delivered treatment and all had
attended training courses in CBT-E run by the manual’s author.
In line with guidance for CBT-ED (Fairburn, 2008; NICE, 2017), up to 40 sessions were
planned. However, this was shortened in the event of rapid change and also if patients no longer
wished to continue with treatment or could not routinely commit to making changes (e.g.
weight restoration). Although some patients saw another member of the team (e.g. dietitian)
1 Following internal discussion, the Service moved to providing twice-weekly sessions and, anecdotally, this was
experienced as positive by both patients and staff.
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for a review, none had additional psychological therapy. Those who required more intensive
treatment (e.g. inpatient admission) following commencement of CBT-ED are included but
classed as non-completers.
As in previous work, ‘non-completion’ was defined as ‘the patient ending treatment before
the agreed termination point (defined by patient and clinician)’ (Waller et al., 2014, p. 14);
all other patients were deemed to have completed a course of treatment (see Fig. 1). The
majority of individuals completed treatment earlier than the planned 40 sessions; typically,
patients had completed the relevant steps of treatment and experienced sufficient improvement
in symptoms. Six individuals (9.5%) received more than 40 sessions, agreed in supervision,
all of whom were treatment completers.
Statistical analyses
To obtain outcomes based on intent-to-treat (ITT) analysis, multiple imputation (MI) with
chained equations was conducted for missing data on BMI, Global EDE-Q, SWC, CIA
Total, and CORE-OM Total. Questionnaire responses were imputed at scale level given
high internal consistency and construction from many items (Graham, 2009). Square-root
transformation reduced the degree of non-normality, so transformed variables formed the basis
for analysis (back-transformed to aid interpretation of results). Transformation did not correct
non-normality in distribution of ED behaviours (e.g. binge eating), so MI was conducted
on untransformed data given the preference for MI to other missing data methods (Graham,
2009).
The imputation model contained pre-treatment age and BMI as predictors and was based
on linear regression for continuous variables. Twenty datasets for each outcome variable were
generated. A similar procedure was carried out for ED behaviours, with the exception that
imputations were estimated from age, BMI and separate ED behaviours. Cohen’s d is reported
as a measure of effect size, obtained from paired samples t-tests for pre–post analysis.
In order to identify predictors of treatment completion, baseline variables were compared
with independent samples t-tests, followed by logistic regression analysis (forward entry)
with significant variables. The model was run with backward entry, but this did not affect the
results.
To investigate the effect of treatment duration, partial correlations (controlling for EDE-Q
and BMI at pre-treatment) were used to assess the relationship between number of sessions
and BMI change (post-treatment BMI minus pre-treatment BMI) and EDE-Q at post-treatment
(transformed data) (e.g. see Bell et al., 2017).
Results
Intent-to-treat analysis
Looking at the sample as a whole, there was a significant main effect of treatment on all
variables (see Table 2). At the end of treatment, nine individuals (14.3%) met criteria for full
remission with a further 22 (34.9%) partial remission; 22 of these (71.0%) were treatment
completers. Specific numbers regarding each remission criterion are provided in Table 2.
Looking at diagnostic differences, Table 3 presents further information for AN and atypical
AN groups. No significant differences were found between the two groups.
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Table 2. Changes in symptomatology over the course of treatment.
Treatment completers (n = 34) All participants (n = 63)
Mean (standard error) Mean (standard error)
Measure Pre Post t Cohen’s d p Pre Post t Cohen’s d p
BMI 17.04 (0.18) 19.14 (0.25) –6.97 1.72 <.001 16.86 (0.14) 18.24 (0.23) –8.14 1.46 <.001
Global EDE-Q 3.90 (0.19) 2.01 (0.25) 5.95 1.46 <.001 3.71 (0.16) 2.07 (0.21) 6.52 1.17 <.001
SWC 4.12 (0.22) 2.45 (0.29) 5.15 1.27 <.001 4.01 (0.18) 2.48 (0.22) 5.75 1.03 <.001
Total ED behaviours∗ 23.74 (6.15) 10.22 (3.97) 2.27 0.56 .023 14.33 (3.44) 7.24 (2.65) 1.97 0.35 .05
CORE Total 18.34 (1.14) 11.68 (1.30) 4.26 1.05 <.001 18.79 (0.86) 12.50 (1.16) 4.53 0.81 <.001
CIA Total‡ 31.17 (1.72) 14.82 (2.14) 5.66 1.39 <.001 31.94 (1.315) 16.01 (1.83) 6.34 1.16 <.001
Remission outcome
Global EDE-Q <2.77 6 (17.6%) 25 (73.5%) – – – 16 (25.4%) 46 (73.0%) – – –
BMI >18.5 – 23 (67.6%) – – – – 30 (47.6%) – – –
Absence of
behavioural
symptoms
5 (14.7%) 12 (35.3%) – – – 13 (20.6%) 18 (28.6%) – – –
Full remission – 7 (20.6%) – – – – 9 (14.3%) – – –
Partial remission – 15 (44.1%) – – – 5 (7.9%) 22 (34.9%) – – –
∗Sum of: objective binge eating episodes, self-induced vomiting, laxative use, excessive exercise; n = 27 (completers) and n = 54 (ITT). ‡n = 33
(completers) and n = 62 (ITT) as one individual did not complete this measure at start-of-treatment.
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Table 3. Differences in outcome in anorexia nervosa (AN) and atypical AN (ITT)
AN (n = 45) Atypical AN (n = 18) Test statistic p-value
Treatment non-completers, N (%) 20 (44.4%) 9 (50.0%) χ2 = 0.160 0.689
EDE-Q Global change∗, mean (SE) 1.76 (0.27) 1.48 (0.51) t = –0.525 0.600
BMI change∗, mean (SE) 1.31 (0.27) 1.24 (0.28) t = 0.161 0.872
Remission outcome
Global EDE-Q <2.77, N (%) 33 (73.3%) 13 (72.2%) χ2 = 0.008 0.928
BMI >18.5, N (%) 20 (44.4%) 10 (55.6%) χ 2 = 0.636 0.425
∗Change in score from pre-treatment to post-treatment.
Treatment completion
Twenty-nine individuals (46.0%) did not complete CBT-ED. On average, patients received
23.1 sessions of CBT-ED (range = 3 to 61) over 30.4 weeks (2 to 75). Completers attended
more sessions that non-completers (30.6 vs 14.4, t (61) = 6.591, p < .001).
Treatment duration
Of note, 76% of those deemed to have completed CBT-ED did not require 40 sessions. Partial
correlations (controlling for pre-treatment EDE-Q Global and BMI) were significant between
number of treatment sessions and BMI change (r = .474, p = .003) but not EDE-Q Global at
post-treatment (r = –.110, p = .522).
Outcomes of treatment completers
For those who completed a course of CBT-ED, there was a considerable response on a number
of symptom measures, with large effect sizes (see Table 2). Mean BMI gain was 2.11 kg m–2
(SE = 0.27) and around two-thirds (23/34; 67.6%) achieved a BMI ≥ 18.5. This change was
significantly greater than the +0.50 kg m–2 (SE = 0.21) for non-completers (t (4044) = 4.627,
p < .001). There was also significant improvement on a measure of psychological distress, and
positive changes in ED behaviours. Seven individuals (20.6%) met criteria for full remission
with a further 15 (44.1%) for partial remission.
Effects on psychosocial impairment
Mean CIA scores had decreased significantly at end-of-treatment, with a large effect size. The
mean score for completers at end-of-treatment was just below the cut-off for case status of 16
(Bohn et al., 2008), and 20 (58.8%) scored below this. For the intent-to-treat sample, the mean
was slightly higher and 37 (58.7%) scored below the cut-off.
Predictors of treatment completion
Comparison at baseline (start-of-treatment) revealed no differences between those who
completed treatment and those who did not on BMI, SWC, EDE-Q Global, CORE Total
or CIA Total scores. Presence and frequency (two separate variables) of binge eating and
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purging did differ, with completers more likely to experience binge eating and purging
(χ2 (1) = 6.833, p = .009) and more episodes of binge eating and purging (23.7 vs 4.93,
t (52) = 2.927, p = .006). This variable remained significant in regression analyses whether
considered as a binary (present/not) or continuous variable. Median-centring (see Kraemer and
Blasey, 2004) produced identical results.
Discussion
Underweight EDs represent some of the most difficult psychiatric illnesses to treat, although
emerging evidence suggests that many patients are able to make significant gains in outpatient
treatment (e.g. Fairburn et al., 2013). Application to ‘real-world’ samples is formative, in part
as existing case series have largely included individuals with AN only as part of larger analyses.
However, this study complements well-conducted trials (e.g. Byrne et al., 2017; Fairburn et al.,
2013) in reporting outcomes for adults with low-weight EDs following outpatient psychological
treatment in a ‘real-world’ setting.
The proportion of individuals who completed treatment in the current study (54%) is
comparable to other ‘real-world’ studies (e.g. Signorini et al., 2017: 50%; Turner et al., 2015:
55%) and is slightly smaller than RCTs for underweight patients (e.g. Byrne et al., 2017:
66.7%; Fairburn et al., 2013: 64%). As this sample wholly consisted of individuals who were
underweight, results suggest that completion rates for CBT-ED may not differ greatly across
diagnoses, although larger studies will be needed to test this assumption. Of note, treatment
completers received an average of around 31 sessions of CBT-ED, far less than typically
recommended (e.g. Fairburn, 2008). A complete explanation for this is unclear, given that
adherence was not assessed, although it has been suggested that it might be possible to develop
briefer versions of CBT-ED, even for those who are underweight, or for certain patients to
move through the stages of treatment more rapidly than others (Waller et al., 2018). For
example, Byrne et al. (2017) amended length of treatment for AN to reflect the magnitude of
weight restoration required, although no such modification was explicitly applied in the current
study. Partial support for this endorsement comes from the fact that duration of treatment was
related only to change in BMI, and not ED pathology, suggesting that those who remained in
treatment longer restored more weight (cf. Bell et al., 2017; Rose and Waller, 2017). However,
as outcomes were not recorded other than at pre- and post-treatment, more detailed analysis
(e.g. of session-by-session change) would be beneficial to determine the optimal number of
sessions required for significant change within CBT-ED.
Duration of illness in the current sample was longer than that of both Fairburn and
colleagues (2013) and Byrne et al. (2017), although other pre-treatment characteristics
(e.g. gender ratio, mean BMI, degree of psychosocial impairment) were comparable. Given
such similarities, existing data repeatedly points to the finding that attrition in ‘real-world’
samples exceeds that in research settings, and is related to poorer outcome overall (e.g. Byrne
et al., 2011).
In terms of weight restoration – a key goal for remission from underweight EDs –
CBT-ED completers restored just over two BMI points from start to end of treatment. In
terms of remission rates, a BMI of at least 18.5 kg m–2 was achieved by over 60% of treatment
completers in Fairburn et al. (2013) and over 50% of the total sample in Byrne et al. (2017).
Minimal ED pathology was achieved by 80% of those who completed treatment in Fairburn
et al. (2013). In the current study, over two-thirds of completers achieved weight restoration
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(just under half of the ITT sample) and nearly three-quarters reported minimal ED pathology.
Overall, results are encouraging given the low body weight (BMI range at start of treatment =
14.8 to 18.5) and lack of strict treatment monitoring, although more needs to be done to improve
outcome for all patients given the smaller treatment effects in ITT analyses. Close adherence to
evidence-based CBT-ED is a possible explanation for the positive results (Linardon et al., 2017),
although such interpretations should be cautious as no measure of adherence was included.
Other secondary outcomes were also promising, with levels of psychological distress
significantly improved following treatment, in addition to reported impairment as a result of
ED pathology (see also Byrne et al., 2017). Therefore, findings support existing data that those
who complete treatment report better outcomes than those who do not (e.g. see Fairburn et al.,
2015). However, given that positive results were also seen in the ITT condition (with around
half achieving at least partial remission), problems around impaired access to psychological
treatments (see Kazdin et al., 2017) and treatment completion also demand resolution.
Only one variable emerged as a significant predictor of outcome – presence of binge eating
and purging was positively associated with treatment completion. However, this was highly
unexpected given results of both non-randomized studies (e.g. Fairburn et al., 2013) and reviews
(e.g. Vall and Wade, 2015) which suggest that higher levels of these behaviours are associated
with worse outcome. Although this finding could be due to limitations of the study, such as
a small number of non-completers who engaged in binge eating and purging at the start of
treatment (n = 4) and lack of randomization, other explanations are possible. It could be,
for example, that individuals were motivated to address this behaviour as part of CBT-ED
(e.g. Vitousek et al., 1998) and therefore remained in treatment. It is also possible that the
early focus on reducing binge eating and purging was associated with positive outcomes (e.g.
see Brown et al., 2013). Other studies (e.g. Turner et al., 2015) have, however, failed to find
that the presence of binge eating and purging predicts outcome and therefore more study is
warranted, perhaps considering the timing of any change in these symptoms.
Limitations of the current study include the small number of male cases and use of self-
report data in assessing both symptomatology and impairment. Although the sample size was
favourable compared with other studies of AN, this was too small to conduct detailed statistical
analyses, such as moderator and mediator effects and certain subgroup analyses (e.g. presence
of binge eating and purging). Although we considered diagnostic differences, it was not possible
to look at outcomes of different groups subtyped by behavioural symptoms. Use of ICD-10
criteria (WHO, 2016), which do not include presence of purging as an essential criterion for
AN diagnosis, also limited this possibility. One further weakness of the study is also perhaps its
major strength. The CBT-ED conducted, whilst closely aligned to a manual (Fairburn, 2008),
was not uniform; a number of therapists delivered the treatment and the number of sessions
received by completers varied from 17 to 61. However, this also speaks to existing evidence
that CBT-ED can be delivered effectively in ‘real-world’ settings when core strategies are
followed (Rose and Waller, 2017; Turner et al., 2015; Waller et al., 2018).
Overall the results presented here suggest that individuals with AN and atypical AN who
are underweight can be treated effectively with CBT-ED in a ‘real-world’ setting. Outcomes
are similar to RCTs and, taken together, suggest that evidence-based treatments can be
readily applied with individuals with EDs in ‘real-world’ settings. As Turner et al. (2015)
conclude, the focus should now be on enhancing retention in evidence-based treatments,
given that those who adhere to treatment (i.e. completers) generally report good clinical
outcomes.
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